These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 5498807)
1. [Chromosome investigations in lymphocytes and bone marrow from long term methotrexate-treated psoriatics]. Sachsse W; Denk R Arch Klin Exp Dermatol; 1970; 239(3):275-81. PubMed ID: 5498807 [No Abstract] [Full Text] [Related]
2. Human mitotic and meiotic chromosome damage following in vivo exposure to methotrexate. Melnyk J; Duffy DM; Sparkes RS Clin Genet; 1971; 2(1):28-31. PubMed ID: 5111752 [No Abstract] [Full Text] [Related]
4. Cytogenetic effects of methotrexate on human cells in vivo: comparison between results obtained by chromosome studies on bone-marrow cells and blood lymphocytes and by the micronucleus test. Jensen MK; Nyfors A Mutat Res; 1979 Oct; 64(5):339-43. PubMed ID: 514299 [TBL] [Abstract][Full Text] [Related]
5. Chromosome studies of bone marrow cells and peripheral blood lymphocytes from diphenylhydantoin-treated patients. Alving J; Jensen MK; Meyer H Mutat Res; 1977 Jul; 48(3-4):361-5. PubMed ID: 876272 [TBL] [Abstract][Full Text] [Related]
6. Chromosome studies in patients treated with azathioprine and amethopterin. Jensen MK Acta Med Scand; 1967 Oct; 182(4):445-55. PubMed ID: 6059136 [No Abstract] [Full Text] [Related]
7. [Acute bone marrow suppression with low-dosage methotrexate]. Brussaard HE; van Eijk CL; van Toorn DW; van Seters WA; de Wit RF Ned Tijdschr Geneeskd; 1987 Dec; 131(51):2369-72. PubMed ID: 3696284 [No Abstract] [Full Text] [Related]
11. [Suppression of bone marrow after drug interaction]. Spigset O; Messner T Lakartidningen; 1993 Jun; 90(22):2138-40. PubMed ID: 8502067 [No Abstract] [Full Text] [Related]
12. Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics. Nyfors A Dan Med Bull; 1978 Oct; 25(5):208-11. PubMed ID: 359259 [No Abstract] [Full Text] [Related]
13. The relation of HL-A antigens to liver histology in methotrexate-treated psoriatics. Nyfors A; Svejgaard A Acta Derm Venereol; 1976; 56(3):235-8. PubMed ID: 59509 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate in the treatment of psoriasis. Med Lett Drugs Ther; 1972 Jun; 14(12):41-2. PubMed ID: 4567562 [No Abstract] [Full Text] [Related]
15. Folic-acid antagonists in psoriasis. Br Med J; 1966 May; 1(5499):1313. PubMed ID: 5934371 [No Abstract] [Full Text] [Related]
16. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics. Zachariae H; Søgaard H; Heickendorff L Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey. Nyfors A Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451 [No Abstract] [Full Text] [Related]
18. Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study. Nyfors A; Jensen H Dermatologica; 1983; 167(5):260-1. PubMed ID: 6653851 [TBL] [Abstract][Full Text] [Related]
19. Liver ultrastructure in psoriatics related to methotrexate therapy. 2. Findings in bile ducts from 11 methotrexate treated psoriatics and 2 controls. Hopwood D; Nyfors A Acta Pathol Microbiol Scand A; 1977 Nov; 85(6):801-11. PubMed ID: 602767 [TBL] [Abstract][Full Text] [Related]
20. Letter: Renal function in methotrexate treated psoriatics. Kennedy C; Baker H Br J Dermatol; 1976 Jun; 94(6):702-3. PubMed ID: 949463 [No Abstract] [Full Text] [Related] [Next] [New Search]